Email Us Here

FDA Orders Baxter to Stop Advertising TISSEEL as Superior to Other Hemostatic Products

The warning further stated that Baxter's Presentation and Brochure included claims suggesting that the FDA approval of TISEEL was for a broader indication that it had actually intended.